03.02.2025 • News

Julie Kim to Succeed Christophe Weber as CEO of Takeda

Takeda has appointed Julie Kim, currently president of the company’s US business unit, to succeed Christophe Weber as CEO in June 2026, who will retire after 12 years in this role.

Kim joined Takeda in 2019 through the acquisition of Shire, where she held several roles with increasing responsibility. She became the president of the Plasma-Derived Therapies business unit and held this position until April 2022, when she became president of the US business unit and US country head.

With three decades working in health care and leadership positions at global, regional, country and functional levels, her experiences cover a variety of therapeutic areas, international market access, country and regional general management, marketing and emerging market development.

Kim earned an MBA from the J. L. Kellogg Graduate School of Management at Northwestern University and a bachelor’s degree in economics from Dartmouth College.

Julie Kim to Succeed Christophe Weber as CEO of Takeda

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Top-Feature

most read